AII
RDY icon

AGF Investments Inc’s Dr. Reddy's Laboratories RDY Stock Holding History

AGF Investments Inc’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$5.19M Buy
+495,600
New +$5.28M 0.05% 209

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AGF Investments Inc's RDY Position: Q3 2022 in Review

AGF Investments Inc opened a new position in Dr. Reddy's Laboratories (RDY) in Q3 2022: 495,600 shares worth $5.19M. The stake represents 0.05% of the portfolio and ranks #209 among its holdings.

150 funds tracked by Wall St. Rank hold RDY as of Q3 2022.

  • AGF Investments Inc held 495,600 shares of Dr. Reddy's Laboratories worth $5.19M as of Q3 2022.
  • Dr. Reddy's Laboratories was a new AGF Investments Inc position in Q3 2022.
  • Dr. Reddy's Laboratories made up 0.05% of AGF Investments Inc's portfolio in Q3 2022, its #209 holding.
  • 150 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2022.

Based on AGF Investments Inc's 13F filing for Q3 2022, filed 10 Nov 2022.